These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study. Arch Intern Med; 1989 May; 149(5):1036-40. PubMed ID: 2785785 [TBL] [Abstract][Full Text] [Related]
4. Administration of filgrastim in two patients with drug-induced agranulocytosis. Castanheira D; Marzella M; Skirvin JA Pharmacotherapy; 1998; 18(6):1347-51. PubMed ID: 9855337 [TBL] [Abstract][Full Text] [Related]
9. Multifocal myoclonus induced by trimethoprim-sulfamethoxazole therapy in a patient with nocardia infection. Dib EG; Bernstein S; Benesch C N Engl J Med; 2004 Jan; 350(1):88-9. PubMed ID: 14702438 [No Abstract] [Full Text] [Related]
10. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Yao F; Behling CA; Saab S; Li S; Hart M; Lyche KD Am J Gastroenterol; 1997 Jan; 92(1):167-9. PubMed ID: 8995964 [No Abstract] [Full Text] [Related]
11. [Transient agranulocytosis in the course of treatment with sulfamethoxazole-trimethoprim]. Destaing F; Villand J; Carli H; Carli PM; Martin F; Klepping C Ann Med Interne (Paris); 1972 Feb; 123(2):129-34. PubMed ID: 5055069 [No Abstract] [Full Text] [Related]
12. [Tremor produced by trimethoprim-sulfamethoxazole]. de Arce Borda AM; Goenaga Sánchez MA Neurologia; 2000; 15(6):264-5. PubMed ID: 11002706 [No Abstract] [Full Text] [Related]
13. Gingival hyperplasia: a new side effect associated with trimethoprim-sulfamethoxazole (TML-SMX) treatment in pulmonary nocardiosis. Caron F; Meurice JC; Dore P; Perault MC; Breux JP; Patte F Therapie; 1997; 52(1):73-4. PubMed ID: 9183926 [No Abstract] [Full Text] [Related]
14. Life threatening hyperkalemia chronic kidney diseases patients treated with trimethoprim-sulfamethoxazole: a case series. Calderón-Ortiz R; Colton-Verge P; Muñiz-Ortega M; Lespier L; Córdova H Bol Asoc Med P R; 2011; 103(3):15-7. PubMed ID: 23210327 [TBL] [Abstract][Full Text] [Related]
15. Co-trimoxazole and genital ulceration. Cherian G Int J Clin Pract; 2001 Mar; 55(2):151. PubMed ID: 11321861 [No Abstract] [Full Text] [Related]
16. Familial tendency in hypersensitivity reactions to co-trimoxazole. Mohanasundaram J; Rajaram S; Mohanasundaram S J Indian Med Assoc; 1998 Jan; 96(1):21-2. PubMed ID: 9601187 [No Abstract] [Full Text] [Related]
17. [Severe metabolic acidosis in a patient treated with trimethoprim-sulfamethoxazole. Physiopathological facts]. Quintela Fandiño M; Coto López A; Fernández-Miranda C An Med Interna; 2003 Aug; 20(8):443-4. PubMed ID: 14516274 [No Abstract] [Full Text] [Related]
18. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype. Ozkaya-Bayazit E; Akar U J Am Acad Dermatol; 2001 Nov; 45(5):712-7. PubMed ID: 11606921 [TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed human immunodeficiency virus after sepsis-like reaction of trimethoprim-sulfamethoxazole. Moran KA; Ales NC; Hemmer PA South Med J; 2001 Mar; 94(3):350-2. PubMed ID: 11284528 [TBL] [Abstract][Full Text] [Related]
20. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization. Kardaun SH; de Waard MM; de Monchy JG Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967 [No Abstract] [Full Text] [Related] [Next] [New Search]